TY - GEN
T1 - Quantifying Fluorescent Intensity Signal from Combined Optical Coherence Tomography and Near Infrared Fluorescence Imaging
AU - Danskin, T.
AU - Harkhoe, R.
AU - Sterkenburg, A. J.
AU - Nagengast, W. B.
AU - de Boer, J. F.
N1 - Publisher Copyright: © 2023 SPIE. All rights reserved.
PY - 2023
Y1 - 2023
N2 - Barrett’s Esophagus (BE) is a common pre-cursor condition to esophageal adenocarcinoma (EAC); the monitoring of which can facilitate the detection of dysplastic tissue, and the treatment of subsequent early stage EAC. Early detection of EAC improves survival rates significantly. Optical Coherence Tomography is a low coherence interferometric technique which produces depth scans of tissues. OCT provides morphological information, but lacks in specificity, and so can be combined with Near Infrared Fluorescence imaging, to also retrieve molecular information. Fluorescently labelled monoclonal antibodies can be administered in order to label specific tissues, which can then be imaged using this OCT-NIRF technique. Fluorescently labelled bevacizumab combined with OCT-NIRF imaging will highlight inflamed, dysplastic and pre-/ cancerous tissues, such as BE tissue. Here, a silicon elastomer phantoms are used to quantify the fluorescence intensity signal detected from a dilution of fluorescent bevacizumab: the fluorescent signal intensity is correlated as a function of fluorophore depth and concentration, and ′Svalue of the phantom material.
AB - Barrett’s Esophagus (BE) is a common pre-cursor condition to esophageal adenocarcinoma (EAC); the monitoring of which can facilitate the detection of dysplastic tissue, and the treatment of subsequent early stage EAC. Early detection of EAC improves survival rates significantly. Optical Coherence Tomography is a low coherence interferometric technique which produces depth scans of tissues. OCT provides morphological information, but lacks in specificity, and so can be combined with Near Infrared Fluorescence imaging, to also retrieve molecular information. Fluorescently labelled monoclonal antibodies can be administered in order to label specific tissues, which can then be imaged using this OCT-NIRF technique. Fluorescently labelled bevacizumab combined with OCT-NIRF imaging will highlight inflamed, dysplastic and pre-/ cancerous tissues, such as BE tissue. Here, a silicon elastomer phantoms are used to quantify the fluorescence intensity signal detected from a dilution of fluorescent bevacizumab: the fluorescent signal intensity is correlated as a function of fluorophore depth and concentration, and ′Svalue of the phantom material.
UR - http://www.scopus.com/inward/record.url?scp=85172881528&partnerID=8YFLogxK
U2 - https://doi.org/10.1117/12.2670946
DO - https://doi.org/10.1117/12.2670946
M3 - Conference contribution
VL - 12632
T3 - Proceedings of SPIE - The International Society for Optical Engineering
BT - Optical Coherence Imaging Techniques and Imaging in Scattering Media V
A2 - Vakoc, Benjamin J.
A2 - Wojtkowski, Maciej
A2 - Yasuno, Yoshiaki
PB - SPIE
T2 - Optical Coherence Imaging Techniques and Imaging in Scattering Media V 2023
Y2 - 25 June 2023 through 29 June 2023
ER -